The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
Date
2014-02Journal
Diabetes CareType
Journal ArticleResearch Support, Non-U.S. Gov't
Publisher
American Diabetes AssociationDOI
10.2337/dc13-2248Rights
Archived with thanks to Diabetes careMetadata
Show full item recordAbstract
Identifying glucokinase monogenic diabetes (GCK-MODY) in pregnancy is important, as management is different from management for other forms of gestational diabetes mellitus (GDM) and there is no increased maternal risk of type 2 diabetes. We calculated the population prevalence of GCK-MODY in pregnancy and determined the clinical characteristics that differentiate pregnant women with GCK-MODY from those with GDM.